Director/PDMR Shareholding

RNS Number : 2640H

Medica Group PLC

02 December 2020

 

Medica Group PLC

Director / PDMR Transaction and Shareholding

Medica Group PLC (LSE: MGP, "Medica" or the "Company"), has received notification from Dr Stephen Davies, Medical Director and Responsible Officer of Medica, that on 30 November 2020 he transferred a total of 521,032 ordinary shares of 0.2p in the Company ("Shares") to his wife, Mary Davies, for nil consideration. In addition, Stephen Davies and his wife have sold a total of 1,079,292 ordinary shares at a price of 120.00p per share.

Following these transactions, Stephen Davies has an interest in  576,634 shares, representing 0.5% of the issued share capital of the Company.

Furthermore, the Company also received a notification from Dr Stuart Quin, Chief Executive Officer of Medica Group PLC, that on 1 December 2020 he transferred a total of 60,000 ordinary shares of 0.2p in the Company ("Shares") to his wife Mallika Quin, for nil consideration. Following this transaction, there has been no change in the number of shares in which Stuart Quin has an interest.

The Notification of Dealing Forms for Dr Stephen Davies and Dr Stuart Quin can be found below.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Stephen Davies
2	Reason for the notification
a)	Position/status	Medical Director and Responsible Officer/PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Medica Group PLC
b)	LEI	213800B8XE5FUSZF5Z16
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 0.2p GB00BYV24996
b)	Nature of the transaction	Transfer of Ordinary Shares to Mary Davies
c)	Price(s) and volume(s)	Price (s) Volumes (s) N/A 521,032
d)	Aggregated information -  Aggrated volume -  Price	521,032 N/A
e)	Date of the transaction	30 November 2020
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Stephen Davies
2	Reason for the notification
a)	Position/status	Medical Director and Responsible Officer/PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Medica Group PLC
b)	LEI	213800B8XE5FUSZF5Z16
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 0.2p GB00BYV24996
b)	Nature of the transaction	Market sale
c)	Price(s) and volume(s)	Price (s) Volumes (s) GBP 120.00 1,031,924
d)	Aggregated information -  Aggrated volume -  Price	1,031,924 GBP 120.00
e)	Date of the transaction	30 November 2020
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mary Davies
2	Reason for the notification
a)	Position/status	PCA/ Dr Stephen Davies (Medical Director and Responsible Officer)
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Medica Group PLC
b)	LEI	213800B8XE5FUSZF5Z16
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 0.2p GB00BYV24996
b)	Nature of the transaction	Market sale
c)	Price(s) and volume(s)	Price (s) Volumes (s) GBP 120.00 47,368
d)	Aggregated information -  Aggrated volume -  Price	47,368 GBP 120.00
e)	Date of the transaction	30 November 2020
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Stuart Quin
2	Reason for the notification
a)	Position/status	Chief Executive Officer/PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Medica Group PLC
b)	LEI	213800B8XE5FUSZF5Z16
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 0.2p GB00BYV24996
b)	Nature of the transaction	Transfer of Ordinary Shares to Mallika Quin
c)	Price(s) and volume(s)	Price (s) Volumes (s) GBP 0 60,000
d)	Aggregated information -  Aggrated volume -  Price	60,000 GBP 0
e)	Date of the transaction	1 December 2020
f)	Place of the transaction	Outside a trading venue

 

END

 

 

DSHKKBBBCBDKKBK